Molecular genetics of Beckwith-Wiedemann syndrome

Current Opinion in Pediatrics

Volumn 9, Issue 6, 1997, Pages 623-629

  Li, Madeline ^a   Squire, Jeremy A ^a   Weksberg, Rosanna ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BECKWITH WIEDEMANN SYNDROME; CELL CYCLE; CHROMOSOME 11P; EMBRYONAL CARCINOMA; GENE EXPRESSION; GENE MUTATION; GENOME IMPRINTING; GROWTH; HUMAN; HYPERPLASIA; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

EID: 0031452521     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199712000-00012     Document Type: Review

References (52)

1. Wiedemann H: Complexe malformatif familial avec hernia ombilicale et macroglossie: un syndrome nouveau? J Genet Hum 1964, 13:223-232.
2. Beckwith J: Macroglossia, omphalocele, adrenal cytomegaly, gigantism, and hyperplastic visceromegaly. Birth Defects 1969, V:188-196.
3. Thomburn M, Wright E, Miller C, Smith-Read E: Exomphalos-macroglossia-gigantism syndrome in Jamaican infants. Am J Dis Child 1970, 119:316-321.
4. Carlin M, Escobar L, Ward R, Wielgus T: A reassessment of Beckwith-Wiedemann syndrome (BWS). Am J Hum Genet 1990, 47(suppl):A50.
5. Pettenati MJ, Haines JL, Higgins RR, Wappner RS, Palmer CG, Weaver DD: Wiedamann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum Genet 1986, 74:143-154.
6. Viljoen D, Pearn J, Beighton P: Manifestations and natural history of idiopathic hemlhypertrophy: a review of eleven cases. Clin Genet 1984, 26:81-86.
7. Cohen MM, Jr: Proteus syndrome: clinical evidence for somatic mosaicism and selective review. Am J Med Genet 1993, 47:645-652.
8. Garganta CL, Bodurtha JN: Report of another family with Simpson-Golabi-Behmel syndrome and a review of the literature. Am J Med Genet 1992, 44:129-135.
9. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Foraboaco A, Schlessinger D: Mutations in GPC3, a glyplcan gene, cause the Simpson-Golabi-Behmel overgrowth syndrome [see comments]. Nat Genet 1996, 12:241-247.
10. Perlman M: Perlman syndrome: familial renal dysplasla with Wilms tumor, fetal gigantism, and multiple congenital anomalies [latter]. Am J Med Genet 1986, 25:793-795.
11. Costello JM: Costello syndrome: update on the original cases and commentary. Am J Med Genet 1996, 62:199-201.
12. Nakao M, Sasaki H: Genomic imprinting: significance in development and diseases and the molecular mechanisms. J Biochem (Tokyo) 1996, 120:467-473.
13. Nicholls RD: New insights reveal complex mechanisms involved in genomic imprinting [editorial; comment]. Am J Hum Genet 1994, 54:733-740.
14. Koufos A, Grundy P, Morgan K, Aleck K, Hadro T, Lampkin B, Kalbakji A, Cavenee W: Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet 1989, 44:711-719.
15. Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP: Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet 1989, 44:720-723.
16. Nystrom A, Cheetham JE, Engstrom W, Schofield PN: Molecular analysis of patients with Wiedemann-Beckwith syndrome: II: paternally derived disomies of chromosome 11. Eur J Pediatr 1992, 151:511-514.
17. Pueschel SM, Padre-Mendoza T: Chromosome 11 and Beckwith-Wiedemann syndrome [letter]. J Pediatr 1984, 104:484-485.
18. Weksberg R, Teshima I, Williams BR, Greenberg CR, Pueschel SM, Chernos JE, Fowlow SB, Hoyme E, Anderson IJ, Whiteman DA, et al.: Molecular characterization of cytogenetic alterations associated with the Beckwith-Wiedemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted. Hum Mol Genet 1993, 2:549-556.
19. Moutou C, Junien C, Henry I, Bonaiti-Pellie C: Beckwith-Wiedemann syndrome: a demonstration of the mechanisms responsible for the excess of transmitting females. J Med Genet 1992, 29:217-220.
20. Weksberg R, Squire JA: Molecular biology of Beckwith-Wiedemann syndrome. Med Pediatr Oncol 1998, 27:462-469.
21. Wiedemann HR: Tumours and hemihypertrophy associated with the Wiedemann-Beckwith syndrome. Eur J Pediatr 1983, 141:129.
22. Sotelo-Avila C, Gonzalez-Crussi F, Fowler JW: Complete and incomplete forms of Beckwith-Wiedemann syndrome: their oncogenic potential. J Pediatr 1980, 96:47-50.
23. Weksberg R, Shen DR, Fei YL, Song QL, Squire J: Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet 1993, 5:143-150.
24. Brown KW, Villar AJ, Bickmore W, Clayton-Smith J, Catchpoole D, Maher ER, Reik W: Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. Hum Mol Genet 1996, 5:2027-2032.
25. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE: Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993, 362:749-751.
26. Zhan S, Shapiro DN, Helman LJ: Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J Clin Invest 1994, 94:445-448.
27. Hashimoto K, Azuma C, Koyama M, Ohashi K, Kamiura S, Nobunaga T, Kimura T, Tokugawa Y, Kanai T, Saji F: Loss of imprinting in choriocarcinoma [letter]. Nat Genet 1995, 9:109-110.
28. Rainier S, Dobry CJ, Feinberg AP: Loss of imprinting in hepatoblastoma. Cancer Res 1995, 55:1836-1838.
29. DeChiara TM, Robertson EJ, Efstratiadis A: Parental imprinting of the mouse insulin-like growth factor II gene. Cell 1991, 64:849-859.
30. Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P, Stewart CL: Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 1994, 8:2953-2963.
31. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B: Tumour-suppressor activity of H19 RNA. Nature 1993, 365:764-767.
32. Ohlsson R, Hedborg F, Holmgren L, Walsh C, Ekstrom TJ: Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression. Development 1994, 120:361-368.
33. Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE: Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci U S A 1995, 92:2159-2163.
34. Morison IM, Becroft DM, Taniguchi T, Woods CG, Reevs AE: Somatic overgrowth associated with overexpresslon of insulin-like growth factor II. Nat Med 1996, 2:311-316.
35. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM: Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 1995, 375:34-39.
36. Leighton PA, Saam JR, Ingram RS, Tilghman SM: Genomic imprinting in mice: Its function and mechanism. Biol Reprod 1996, 54:273-278.
37. Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, Ekstrom TJ: Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Oncogene 1995, 11:221-229.
38. Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stehelin D, Coll J, Riou G: High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas: uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene 1996, 12:423-430.
39. Lee MH, Reynisdottir I, Massague J: Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995, 9:639-649.
40. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ: p57kip2, a structurally distinct member of the p21cip1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995, 9:650-662.
41. KIP2.
42. Yan Y, Frisen J, Lee MH, Massague J, Barbacid M: Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development Genes Dev 1997, 11:973-983.
43. KIP2 mutations in mice show remarkable similarities to the spectrum of anomalies seen in Beckwith-Wiedemann syndrome. However, notably absent is an effect on growth.
44. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, et al.: Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996, 12:17-23.
45. Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, et al.: A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997, 15:186-189.
46. Lee M, Hu R, Johnson L, Feinberg A: Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat Genet 1997, 15:181-185. This study reports that the most distal cluster of BWS-associated translocation breakpoints falls within the coding region of one gene in the 11p15 region.
47. Saitoh S, Buiting K, Rogan PK, Buxton JL, Driscoll DJ, Arnemann J, Konig R, Malcolm S, Horsthemke B, Nicholls RD: Minimal definition of the imprinting center and fixation of chromosome 15q11-q13 epigenotype by imprinting mutations. Proc Natl Acad Sci U S A 1996, 93:7811-7815.
48. Mannens M, Hoovers JM, Redeker E, Verjaal M, Feinberg AP, Little P, Boavida M, Coad N, Steenman M, Bliek J, et al.: Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasla. Eur J Hum Genet 1994, 2:3-23.
49. Dittrich B, Buiting K, Korn B, Rickard S, Buxton J, Saitoh S, Nicholls RD, Poustka A, Winterpacht A, Zabel B, Horsthemke B: Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nat Genet 1996, 14:163-170.
50. Herzing L, Romer J, Horn J, Ashworth A: Xist has properties of the X-chromosome inactivation centre. Nat Genet 1997, 386:272-275.
51. Lee J, Jaenisch R: Long-range cis effects of ectopic X-inactivation centres on a mouse autosome. Nat Genet 1997, 386:275-279.
52. Clericuzio CL, D'Angio GJ, Duncan M, Green DM, Knudson AG Jr: Summary and recommendations of the workshop held at the first international conference on molecular and clinical genetics of childhood renal tumors. Med Pediatr Oncol 1993, 21:233-236.